In this article, we discuss the 5 companies to consider in the portfolio of Kevin O’Leary. If you want to read about some more companies in the stock portfolio of Kevin O’Leary, go directly to Kevin O’Leary’s Stock Portfolio: 10 Stock Picks for 2023.
5. Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ) currently works with three sectors: Consumer, Pharmaceutical, and Medical Devices & Diagnostics after becoming a well-known worldwide healthcare company. Johnson & Johnson (NYSE:JNJ) has about 250 subsidiary businesses that operate in 60 countries and sell their goods in more than 175 nations.
The company’s most recent earnings report was delivered on January 24th, 2023 for the fourth quarter and full year. For the fourth quarter, adjusted EPS of $2.35 beat by $0.11, while revenue of $23.7 billion missed slightly.
Johnson & Johnson (NYSE:JNJ) forecasts 3.5% adjusted earnings-per-share growth and 4% adjusted operational revenue growth for 2023 (without the COVID-19 vaccine).
It is pertinent to mention that Johnson & Johnson (NYSE:JNJ) is now known as a Dividend King because it has increased its dividend for 60 years consecutively. Many renowned money managers own the stock. J&J, for instance, is a dividend stock owned by Kevin O’Leary.
4. Merck & Co., Inc. (NYSE:MRK)
One of the biggest healthcare organizations in the world is Merck & Co., Inc. (NYSE:MRK). Merck produces pharmaceuticals, vaccines, biological treatments, and items for animal health. Merck has 67,000 employees worldwide and makes about $59 billion in revenue each year.
Merck & Co., Inc. (NYSE:MRK) released its fourth quarter and annual results for the period ending December 31, 2022, on February 2nd, 2023. Revenue increased by 2.1% to $13.8 billion for the quarter, surpassing estimates by $140 million. Adjusted net income of $4.1 billion, or $1.62 per share, was $0.08 higher than anticipated but was down from adjusted net income of $4.6 billion, or $1.81 per share, in the preceding year. Revenue for the year increased by 22% to $59.3 billion. The adjusted earnings-per-share came to $7.48, exceeding the company’s highest-end forecast.
Merck & Co., Inc. (NYSE:MRK) also gave some operating guidelines for 2023. The company anticipates sales in the $57.2 billion to $58.7 billion range and adjusted earnings-per-share in the $6.80 to $6.95 range. This would represent a reduction of 8% from 2022 at the midpoint.
3. S&P Global Inc. (NYSE:SPGI)
With a market value of $113 billion and annual revenue of around $12 billion, S&P Global Inc. (NYSE:SPGI) is a global provider of financial services and business information. Credit ratings, benchmarks and indexes, analytics, and other data are offered to participants in the capital markets, automobile markets, and commodities markets through its numerous segments.
Since 1937, S&P Global Inc. (NYSE:SPGI) has grown its dividend payout every year for 50 years in a row.
Sales increased 41% year over year to $2.94 billion, beating projections by $60 million. With the addition of the newly purchased IHS Markit business and a 3% increase from legacy operations, market intelligence sales increased 83% to $1.037 billion.
2. Microsoft Corporation (NASDAQ:MSFT)
The Redmond, Washington-based Microsoft Corporation (NASDAQ:MSFT) was established in 1975 and offers hardware and software to both businesses and consumers. Operating systems, commercial software, software development tools, video games and gaming gear, and cloud services are among its products.
Microsoft Corporation (NASDAQ:MSFT) released its financial data for the second quarter of its fiscal year, which concludes on June 30th, in late January. Revenue for the company increased by 2% over the same period the prior year. Productivity & Business Processes and Intelligent Cloud both experienced growth, growing 22% and 7%, respectively. Microsoft’s high-growth cloud platform Azure had a 31% increase in sales. Personal computing, meanwhile, suffered a -19% decline in income.
1. The Home Depot, Inc. (NYSE:HD)
Since its founding in 1978, The Home Depot, Inc. (NYSE:HD) has expanded into the largest home improvement retailer, with about 2,300 locations across the United States, Canada, and Mexico. The annual revenue for Home Depot is estimated to be $130 billion. This is one of the reasons why Kevin O’Leary has invested in the stocks of the company so heavily.
On November 15, The Home Depot, Inc. (NYSE:HD) released its third quarter 2022 financial results. Sales for the third quarter rose 5.6% year over year to $38.9 billion, according to the business. Comparable sales increased 4.3% in the quarter and 4.5% in the United States particularly. In comparison to Q3 2021’s $4.1 billion, or $3.92 per share, net earnings came to $4.3 billion, or $4.24 per share.
You can also take a peek at 10 Growth Stocks with Upside Potential and 14 Best Agriculture Stocks To Buy Now.
